文献速递慢性肾脏病血液净化与透析

肾脏缺氧在糖尿病肾病发病机制中的作用:SGLT2抑制剂等新型肾保护剂的潜在靶点

The role of renal hypoxia in the pathogenesis of diabetic kidney disease: a promising target for newer renoprotective agents including SGLT2 inhibitors?
PubMed 文献 · Kidney Int · 2020-04-26

本文综述慢性缺氧假说在糖尿病肾病发病机制中的作用。糖尿病通过微血管损伤损害氧供、通过SGLT上调与高滤过增加钠重吸收而加剧氧耗,形成缺氧损伤恶性循环。文章汇总动物与人类研究证据,并讨论BOLD-MRI等新影像技术及SGLT2抑制剂改善肾缺氧的肾脏保护潜力。

要点

  • 慢性缺氧可能是驱动糖尿病肾病及其他慢性肾脏病的主要病理生理通路。
  • 糖尿病通过微血管损伤降低氧供、通过钠重吸收增加升高氧耗,破坏氧平衡。
  • SGLT2抑制剂可能通过改善肾脏缺氧发挥肾脏保护作用。

核心结论

  • 慢性缺氧假说认为缺氧是驱动糖尿病肾病及其他病因慢性肾脏病的原发病理生理通路。
  • 改善肾脏缺氧可能是SGLT2抑制剂等新型肾保护剂的作用靶点。

研究设计与样本

  • 本文为综述,围绕慢性缺氧在糖尿病肾病发病机制中的作用及其治疗靶点前景展开。
  • 综述内容涵盖缺氧的细胞机制、动物与人类研究中肾脏缺氧的证据,以及BOLD-MRI等新影像技术和SGLT2抑制剂的保护作用。

主要发现

  • 缺氧源于氧供与氧耗之间的失配,氧供主要决定因素是肾脏灌注,氧耗主要驱动因素是主动钠重吸收。
  • 糖尿病时高血糖相关微血管损伤损害氧供,SGLT上调与肾小球高滤过增加钠重吸收而加剧氧耗。
  • 由此产生的缺氧性损伤形成毛细血管损伤、炎症、细胞外基质沉积直至纤维化和肾单位丢失的恶性循环。

临床怎么用

  • 可将改善肾脏缺氧作为糖尿病肾病新型肾保护剂研发与评估的潜在方向。
  • BOLD-MRI等新影像模态有望用于评估肾脏氧合状态。
  • SGLT2抑制剂可能通过改善肾脏缺氧发挥肾脏保护作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Diabetic kidney disease is the most common cause of end-stage kidney disease and poses a major global health problem. Finding new, safe, and effective strategies to halt this disease has proven to be challenging. In part that is because the underlying mechanisms are complex and not fully understood. However, in recent years, evidence has accumulated suggesting that chronic hypoxia may be the primary pathophysiological pathway driving diabetic kidney disease and chronic kidney disease of other etiologies and was called the chronic hypoxia hypothesis. Hypoxia is the result of a mismatch between oxygen delivery and oxygen demand. The primary determinant of oxygen delivery is renal perfusion (blood flow per tissue mass), whereas the main driver of oxygen demand is active sodium reabsorption. Diabetes mellitus is thought to compromise the oxygen balance by impairing oxygen delivery owing to hyperglycemia-associated microvascular damage and exacerbate oxygen demand owing to increased sodium reabsorption as a result of sodium-glucose cotransporter upregulation and glomerular hyperfiltration. The resultant hypoxic injury creates a vicious cycle of capillary damage, inflammation, deposition of the extracellular matrix, and, ultimately, fibrosis and nephron loss. This review will frame the role of chronic hypoxia in the pathogenesis of diabetic kidney disease and its prospect as a promising therapeutic target. We will outline the cellular mechanisms of hypoxia and evidence for renal hypoxia in animal and human studies. In addition, we will highlight the promise of newer imaging modalities including blood oxygenation level-dependent magnetic resonance imaging and discuss salutary interventions such as sodium-glucose cotransporter 2 inhibition that (may) protect the kidney through amelioration of renal hypoxia.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Hesp AC, Schaub JA, Prasad PV, et al. The role of renal hypoxia in the pathogenesis of diabetic kidney disease: a promising target for newer renoprotective agents including SGLT2 inhibitors? Kidney Int. 2020. PMID: 32739206. doi:10.1016/j.kint.2020.02.041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。